Raymond James Financial Inc Maia Biotechnology, Inc. Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
20Shares Held
2.35MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.1MShares$1.15 Million0.0% of portfolio
-
Centric Wealth Management575KShares$597,8930.21% of portfolio
-
Geode Capital Management, LLC Boston, MA271KShares$281,8980.0% of portfolio
-
Marshall Wace, LLP London, X0110KShares$114,8850.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$81,6610.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $11.4M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...